GSK
441576
Business Introduction
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people's lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients' needs and have the highest probability of success.
We're uniting science, technology, and talent to get ahead of disease together.
Find out more:
Our approach to R&D
Position Summary
We are seeking a Platform Modalities Leader to provide enterprise-level scientific leadership for the modernisation and evolution of Analytical Chemistry platforms supporting developing and complex therapeutic modalities.
This role owns the strategic expansion of analytical platform capability beyond the current small-molecule portfolio, enabling robust, scalable, and future - proof analysis of divalent small molecules, drug conjugates including Warhead Linker Payloads for Antibody Drug Conjugates (WLPs for ADCs), and oligonucleotides .
The position plays a critical role in ensuring analytical platforms are positioned to meet both near-term pipeline demands and longer-term modality evolution, while maintaining the highest standards of scientific excellence.
The successful candidate will be a recognised authority who leads from the laboratory , combining deep hands-on technical expertise with platform-level strategic thinking. Through modernisation of existing capabilities, introduction of new technologies, and integration of high-throughput purification and analytical workflows, this role will shape the future state of analytical platform delivery for emerging modalities.
This is a Scientific leader role G6 with 0 to 6 reports and will require extensive matrix leadership across chemistry, modality, informatics, automation, and technology organisations. Success will depend on the ability to influence direction, set standards, and deliver change across multiple reporting lines, with impact at programme, portfolio, and organisational level. The role will require full-time on-site presence.
Key Responsibilities
Platform Strategy, Ownership & Modernisation
*Provideend - to - end scientific ownership of existing analytical and purification platforms at Stevenage and supporting small molecule and next-generation modalities, including divalent small molecules, WLPs, and oligonucleotides.
*Define and driveplatform strategy and modernisation , ensuring analytical capabilities are scalable, automation-ready, and aligned to future modality and pipeline needs.
Senior Scientific & Technical Leadership
High-Throughput & Workflow Integration
*Drive the strategic integration ofhigh-throughput purification and analytical workflows to enable efficient, end-to-end support of emerging modality pipelines.
Enterprise Collaboration & Influence
*Operate as asenior matrix leader , partnering with Discovery Chemistry, Modality teams, Informatics, Automation, and external collaborators to align platform capabilities with business priorities.
Governance, Quality & Continuous Improvement
*Ensure analytical platforms meet high standards ofquality, safety, and compliance , consistent with organisational and regulatory expectations.
Basic Qualifications & Skills
Preferred Qualifications & Skills